Do-Coop Technologies Reaches DMF and cGMP Milestones for Neowater, its Proprietary Water-Based Nanotechnology

Do-Coop Technologies Ltd., a privately held corporation based in Israel, announced that it has reached two significant milestones for Neowater, its proprietary water-based nanotechnology.

A Type IV Drug Master File has been submitted to the US Food and Drug Administration (FDA) for Neowater. In addition, the first Current Good Manufacturing Practice (cGMP) Neowater manufacturing plant is operational in Israel.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Submit